Literature DB >> 9767367

Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C.

B L Auer1, D Auer, A L Rodgers.   

Abstract

BACKGROUND: Long-term or high-dosage consumption of vitamin C may play a role in calcium oxalate kidney stone formation. The present study was undertaken to determine the biochemical and physicochemical risk factors in a male subject who developed haematuria and calcium oxalate crystalluria after ingestion of large doses of ascorbic acid for 8 consecutive days.
METHODS: Twenty-four-hour urine samples were collected before and during the ascorbic acid ingestion period as well as after the detection of haematuria. A special procedure was implemented for urine collections to allow for oxalate, ascorbate and other urinalysis. Oxalate was determined in the presence of EDTA to prevent in vitro conversion to ascorbic acid, whereas ascorbate itself was determined by manual titration in a redox method using the dye dichlorophenolindophenol. Urinalysis data were used to compute calcium oxalate relative supersaturations and Tiselius risk indices, whereas scanning electron microscopy was used to examine urinary deposits.
RESULTS: Oxalate excretion increased by about 350% during ascorbate ingestion before haematuria. Ascorbate concentrations also increased dramatically but appeared to reach a plateau maximum. Increasing calcium excretion was accompanied by decreasing potassium and phosphate values. The calcium oxalate relative supersaturation and Tiselius risk index increased during vitamin C ingestion and large aggregates of calcium oxalate dihydrate crystals were observed by scanning electron microscopy immediately after the detection of haematuria.
CONCLUSION: High percentage metabolic conversion of ascorbate to oxalate in this subject caused relative hyperoxaluria and crystalluria, the latter manifesting itself as haematuria. Clinicians need to be alerted to the potential dangers of large dose ingestion of vitamin C in some individuals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767367     DOI: 10.1046/j.1365-2362.1998.00349.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  15 in total

Review 1.  Microbial relatives of the seed storage proteins of higher plants: conservation of structure and diversification of function during evolution of the cupin superfamily.

Authors:  J M Dunwell; S Khuri; P J Gane
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 2.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

Review 3.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 4.  Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.

Authors:  M Straub; W L Strohmaier; W Berg; B Beck; B Hoppe; N Laube; S Lahme; M Schmidt; A Hesse; K U Koehrmann
Journal:  World J Urol       Date:  2005-11-29       Impact factor: 4.226

5.  Vitamin C-induced oxalate nephropathy.

Authors:  Jorge Lamarche; Reji Nair; Alfredo Peguero; Craig Courville
Journal:  Int J Nephrol       Date:  2011-03-16

Review 6.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Vitamin C: the known and the unknown and Goldilocks.

Authors:  S J Padayatty; M Levine
Journal:  Oral Dis       Date:  2016-04-14       Impact factor: 3.511

Review 8.  Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease.

Authors:  W G Robertson
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

Review 9.  Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.

Authors:  E Klimant; H Wright; D Rubin; D Seely; M Markman
Journal:  Curr Oncol       Date:  2018-04-30       Impact factor: 3.677

Review 10.  Vitamin C revisited.

Authors:  Heleen M Oudemans-van Straaten; Angelique Me Spoelstra-de Man; Monique C de Waard
Journal:  Crit Care       Date:  2014-08-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.